Your are here: Home // Posts Tagged With drug trials
Growing Safety Concerns about Diabetes Drugs
Growing Safety Concerns about Diabetes Drugs & its Unethical Trials
Dr. David Juurlink, the chief of clinical pharmacology and toxicology at Sunnybrook Health Sciences Center (in Toronto) has urgred FDA to halt the continuing drug trial for diabetes drug rosiglitazone (aka Avandia) as resaerch has proved it as a factor enhancing the proability of cardiovascular diseases in users 30% more than its...
Tags: Avandia, diabetes drugs, Diabetes News, drug trials, drugs, fda, news, rosiglitazone, Thiazolidinediones, trials
